Can Travere Therapeutics Turn the Corner With Its Ambitious New Strategy?
Travere Therapeutics, at a stock price of $19.68, has shown a promising 3.39% increase, indicating potential growth. Focused on rare disease therapies, Travere addresses critical medical needs with a unique…